Osteoclast Differentiation Requires Ascorbic Acid
- 1 June 1998
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 13 (6) , 970-977
- https://doi.org/10.1359/jbmr.1998.13.6.970
Abstract
Osteoclast differentiation assays are usually conducted in alpha minimal essential medium (alpha-MEM). We reasoned that determining which components of this media are critical for osteoclast differentiation might provide insight into the mechanisms that regulate osteoclast differentiation. This study demonstrates that ascorbic acid is the crucial component of alpha-MEM that stimulates differentiation of murine osteoclasts in cocultures with murine mesenchymal support cells. Thus, supplementation with ascorbic acid allows osteoclast differentiation to occur in basal MEM media as well as in RPMI-1640 and basal media Eagle (BME) media. The conclusion that osteoclast differentiation is stimulated by ascorbic acid was obtained whether osteoclast differentiation was induced by 1,25-dihydroxyvitamin D3 or parathyroid hormone, whether ST2 or CIMC-2 cells were used as mesenchymal support cells, and whether osteoclast precursors were obtained from spleen or bone marrow. Time course studies revealed that although ascorbic acid only modestly increases the rate at which osteoclast precursors begin to express tartrate-resistant acid phosphatase, it strongly increases the rate at which precursors fuse into mature, multinucleated cells. Moreover, ascorbic acid strongly increases the life span of both osteoclasts and their precursors. The increases in precursor formation, fusion, and life span induced by ascorbic acid are together responsible for the stimulation of osteoclast differentiation by ascorbic acid. Given the known effects of ascorbic acid on differentiation of mesenchymal cells, it may stimulate osteoclast differentiation indirectly by regulating the differentiation state of the mesenchymal cells that support osteoclast differentiation.Keywords
This publication has 52 references indexed in Scilit:
- Specific Inhibitors of Vacuolar H+‐ATPase Trigger Apoptotic Cell Death of OsteoclastsJournal of Bone and Mineral Research, 1997
- Ketoconazole and phorbol myristate acetate regulate osteoclast precursor fusion in primary murine marrow cultureJournal of Bone and Mineral Research, 1996
- Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.Journal of Clinical Investigation, 1996
- Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysisJournal of Orthopaedic Research, 1996
- Modulation of the resorptive activity of rat osteoclasts by small changes in extracellular pH near the physiological rangeBone, 1996
- In vitro and Ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesisJournal of Bone and Mineral Research, 1995
- The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow.Journal of Clinical Investigation, 1995
- The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role.Journal of Clinical Investigation, 1995
- Involvement of adhesion molecules LFA-1 and ICAM-1 in osteoclast developmentBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Effect of medium pH on osteoclast activity and osteoclast formation in cultures of dispersed rabbit osteoclastsJournal of Bone and Mineral Research, 1993